Skip to main content
GutCited

Bifidobacterium infantis 35624 and other probiotics in the management of irritable bowel syndrome. Strain specificity, symptoms, and mechanisms.

Andrew P Allen, Gerard Clarke, John F Cryan, Eamonn M M Quigley, Timothy G Dinan
Other Current medical research and opinion 2017 21 citations
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'pmid\u003D28436237'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

En bref

Given the prevalence of irritable bowel syndrome, its impact on quality-of-life for some sufferers, as well as recent evidence implicating the gut microbiota in the pathogenesis of IBS, there is a need to understand more fully the role of gut bacteria in IBS.

Used In Evidence Reviews

Similar Papers